Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Sona Nanotech Inc > Dude
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3146)
•••
Comment by Kaiseron May 14, 2021 12:47am
85 Views
Post# 33201504

RE:RE:RE:RE:RE:RE:Dude

RE:RE:RE:RE:RE:RE:Dude

No one pays me anything and posting facts is not bashing.  Just because it may not be to your narrative doesn't mean what I or anyone else says is bashing.

Only reason I am here posting FACTS is for the countless bag holding clowns who own Sona and are actually spreading lies on a covid ticket I own.

Please feel free to show me what I have said about Sona that is a lie? 

MetalsDude wrote: I just don't understand people that come on this forum and just bash the stock. The whole point of being on whatever stock board you're on is to support the stock you're invested in and share news about it. I guess if you're paid basher I can sorta understand but do companies really hire peeps to do that? Peeps actually getting paid for it? If so then what a way to make money lol

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities